The ESG in Life Sciences Summit West - Mastering ESG Compliance & Strategic Sustainability in Life Sciences in 2025. As ESG becomes a key differentiator for securing business and investment, life sciences companies are ramping up sustainability efforts - expanding teams, funding new initiatives, and integrating ESG into corporate strategy. Yet, with shifting global reporting […]

“Toxicity is the killer of ADCs” and remains the primary challenge limiting ADC success in the clinic. From unpredictable off-target effects to non-translating toxicity profiles and dose limiting toxicities, the industry must address key hurdles in preclinical models, patient selection, ADC design, and cross-disciplinary communication to accelerate the next wave of safer, more effective ADCs. The […]

The 3rd Obesity & Weight Loss Summit has been announced and is set to ignite the field.  The summit will unite experts to harness novel targets and GLP combination therapies to improve efficacy, tolerability, and longer lasting clinical outcomes. Join us at this unique, industry-led summit to: Discover groundbreaking combination therapies and novel targets to minimize and manage side […]

Building on recent breakthroughs in gene therapy, 2025 is poised for major advancements in cell transplants, gamma secretase inhibitors, anti-inflammatory programs, and more to address the growing unmet need for more transformative hearing loss treatments. With an aging population and an urgent need to restore a greater spectrum of hearing abilities beyond the scope of […]

The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidates and developmental progress towards clinical and commercial approval. To shine light on emerging areas and the latest progress, the 5th mRNA-Based Therapeutics Summit returns to Boston as the world's largest, end-to-end mRNA conference, […]

This July, the 13th Tumor Models Summit Boston returns, uniting 180+ preclinical and translational experts from biopharma and solution providers. This year’s dual-track program will empower you and your team to implement reproducible, predictive oncology models, and bridge the translational gap in a time- and cost-effective manner. Expect to gain exclusive insights into: The latest […]

The Operationalize: Expanded Access Programs Summit West is coming to San Francisco! (July 29-31). Following the successful Boston and London meetings, the Operationalize Expanded Access Programs Summit West is uniting stakeholders executing Early Access, Expanded Access and Post-Trial Access Programs to share expertise in successfully bridging the gap between innovative clinical research and patients in need. This Summit is […]

The landscape of Fc-mediated therapies is undergoing a radical transformation, driven by precise Fc-receptor targeting and antibody domain modification to unlock new levels of efficacy and safety for unprecedented therapeutic potential in oncology and autoimmune disease treatment. The 5th Fc-Mediated Function Summit is the essential destination for experts driving innovation in Fc-receptor targeting and antibody […]

The 5th Next Generation Gene Therapy Vectors Summit Recent announcements from major pharmaceutical companies scaling back their AAV gene therapy pipelines have raised concerns across the field. However, this is not the end. It is an opportunity to reset, refocus, and rise to the challenge. While issues such as liver toxicity, pre-existing antibodies, and high manufacturing costs remain significant, so […]

As demand for radiopharmaceuticals rises, the industry is focused on strengthening isotope supply, improving patient access, and accelerating therapeutic development. Join us at the 4th Targeted Radiopharmaceuticals Summit US in San Diego this July for the premier platform dedicated to radiopharmaceutical therapeutics and theranostics, featuring: 50+ Expert Speakers from leading biotech, pharma, and research institutions, including Ratio […]